Cargando…
VANGL2 inhibits antiviral IFN-I signaling by targeting TBK1 for autophagic degradation
Stringent control of type I interferon (IFN-I) signaling is critical to potent innate immune responses against viral infection, yet the underlying molecular mechanisms are still elusive. Here, we found that Van Gogh–like 2 (VANGL2) acts as an IFN-inducible negative feedback regulator to suppress IFN...
Autores principales: | , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Association for the Advancement of Science
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10289648/ https://www.ncbi.nlm.nih.gov/pubmed/37352355 http://dx.doi.org/10.1126/sciadv.adg2339 |
_version_ | 1785062324245102592 |
---|---|
author | Hu, Zhiqiang Xie, Yingchao Lu, Jiansen Yang, Jianwu Zhang, Jiahuan Jiang, Huaji Li, Hongyu Zhang, Yufeng Wu, Dan Zeng, Ke Bai, Xiaochun Yu, Xiao |
author_facet | Hu, Zhiqiang Xie, Yingchao Lu, Jiansen Yang, Jianwu Zhang, Jiahuan Jiang, Huaji Li, Hongyu Zhang, Yufeng Wu, Dan Zeng, Ke Bai, Xiaochun Yu, Xiao |
author_sort | Hu, Zhiqiang |
collection | PubMed |
description | Stringent control of type I interferon (IFN-I) signaling is critical to potent innate immune responses against viral infection, yet the underlying molecular mechanisms are still elusive. Here, we found that Van Gogh–like 2 (VANGL2) acts as an IFN-inducible negative feedback regulator to suppress IFN-I signaling during vesicular stomatitis virus (VSV) infection. Mechanistically, VANGL2 interacted with TBK1 and promoted the selective autophagic degradation of TBK1 via K48-linked polyubiquitination at Lys(372) by the E3 ligase TRIP, which serves as a recognition signal for the cargo receptor OPTN. Furthermore, myeloid-specific deletion of VANGL2 in mice showed enhanced IFN-I production against VSV infection and improved survival. In general, these findings revealed a negative feedback loop of IFN-I signaling through the VANGL2-TRIP-TBK1-OPTN axis and highlighted the cross-talk between IFN-I and autophagy in preventing viral infection. VANGL2 could be a potential clinical therapeutic target for viral infectious diseases, including COVID-19. |
format | Online Article Text |
id | pubmed-10289648 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | American Association for the Advancement of Science |
record_format | MEDLINE/PubMed |
spelling | pubmed-102896482023-06-24 VANGL2 inhibits antiviral IFN-I signaling by targeting TBK1 for autophagic degradation Hu, Zhiqiang Xie, Yingchao Lu, Jiansen Yang, Jianwu Zhang, Jiahuan Jiang, Huaji Li, Hongyu Zhang, Yufeng Wu, Dan Zeng, Ke Bai, Xiaochun Yu, Xiao Sci Adv Biomedicine and Life Sciences Stringent control of type I interferon (IFN-I) signaling is critical to potent innate immune responses against viral infection, yet the underlying molecular mechanisms are still elusive. Here, we found that Van Gogh–like 2 (VANGL2) acts as an IFN-inducible negative feedback regulator to suppress IFN-I signaling during vesicular stomatitis virus (VSV) infection. Mechanistically, VANGL2 interacted with TBK1 and promoted the selective autophagic degradation of TBK1 via K48-linked polyubiquitination at Lys(372) by the E3 ligase TRIP, which serves as a recognition signal for the cargo receptor OPTN. Furthermore, myeloid-specific deletion of VANGL2 in mice showed enhanced IFN-I production against VSV infection and improved survival. In general, these findings revealed a negative feedback loop of IFN-I signaling through the VANGL2-TRIP-TBK1-OPTN axis and highlighted the cross-talk between IFN-I and autophagy in preventing viral infection. VANGL2 could be a potential clinical therapeutic target for viral infectious diseases, including COVID-19. American Association for the Advancement of Science 2023-06-23 /pmc/articles/PMC10289648/ /pubmed/37352355 http://dx.doi.org/10.1126/sciadv.adg2339 Text en Copyright © 2023 The Authors, some rights reserved; exclusive licensee American Association for the Advancement of Science. No claim to original U.S. Government Works. Distributed under a Creative Commons Attribution License 4.0 (CC BY). https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution license (https://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Biomedicine and Life Sciences Hu, Zhiqiang Xie, Yingchao Lu, Jiansen Yang, Jianwu Zhang, Jiahuan Jiang, Huaji Li, Hongyu Zhang, Yufeng Wu, Dan Zeng, Ke Bai, Xiaochun Yu, Xiao VANGL2 inhibits antiviral IFN-I signaling by targeting TBK1 for autophagic degradation |
title | VANGL2 inhibits antiviral IFN-I signaling by targeting TBK1 for autophagic degradation |
title_full | VANGL2 inhibits antiviral IFN-I signaling by targeting TBK1 for autophagic degradation |
title_fullStr | VANGL2 inhibits antiviral IFN-I signaling by targeting TBK1 for autophagic degradation |
title_full_unstemmed | VANGL2 inhibits antiviral IFN-I signaling by targeting TBK1 for autophagic degradation |
title_short | VANGL2 inhibits antiviral IFN-I signaling by targeting TBK1 for autophagic degradation |
title_sort | vangl2 inhibits antiviral ifn-i signaling by targeting tbk1 for autophagic degradation |
topic | Biomedicine and Life Sciences |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10289648/ https://www.ncbi.nlm.nih.gov/pubmed/37352355 http://dx.doi.org/10.1126/sciadv.adg2339 |
work_keys_str_mv | AT huzhiqiang vangl2inhibitsantiviralifnisignalingbytargetingtbk1forautophagicdegradation AT xieyingchao vangl2inhibitsantiviralifnisignalingbytargetingtbk1forautophagicdegradation AT lujiansen vangl2inhibitsantiviralifnisignalingbytargetingtbk1forautophagicdegradation AT yangjianwu vangl2inhibitsantiviralifnisignalingbytargetingtbk1forautophagicdegradation AT zhangjiahuan vangl2inhibitsantiviralifnisignalingbytargetingtbk1forautophagicdegradation AT jianghuaji vangl2inhibitsantiviralifnisignalingbytargetingtbk1forautophagicdegradation AT lihongyu vangl2inhibitsantiviralifnisignalingbytargetingtbk1forautophagicdegradation AT zhangyufeng vangl2inhibitsantiviralifnisignalingbytargetingtbk1forautophagicdegradation AT wudan vangl2inhibitsantiviralifnisignalingbytargetingtbk1forautophagicdegradation AT zengke vangl2inhibitsantiviralifnisignalingbytargetingtbk1forautophagicdegradation AT baixiaochun vangl2inhibitsantiviralifnisignalingbytargetingtbk1forautophagicdegradation AT yuxiao vangl2inhibitsantiviralifnisignalingbytargetingtbk1forautophagicdegradation |